Chris Cruickshank

Chris Cruickshank is a Lecturer in the School of Biomedical Sciences at The University of Western Australia (UWA), specializing in clinical biochemistry and toxicology. He concurrently serves as a Medical Scientist-Toxicologist with Clinipath Pathology, focusing on immunoassay and LC-MS/MS testing for therapeutic drug monitoring and drug analysis. His academic role involves teaching in UWA's Master of Clinical Pathology program, while his clinical work emphasizes method development, quality assurance, and staff mentorship in toxicology laboratories.

Education: PhD in Pharmacology (2009) from UWA, focusing on the clinical profile and treatment of methamphetamine withdrawal. BSc (Hons) in related fields.

Research interests center on pharmacology of methamphetamine dependence, neurotoxicity, and clinical applications of toxicology. His publications span drug withdrawal management, psychopharmacology, and medical education innovations. Articles collectively address clinical pharmacology fundamentals, withdrawal symptom mitigation strategies, and translational research bridging academia and clinical practice.

Professional roles include membership on the Royal College of Pathologists Australasia's Toxicology Advisory Committee. He contributes to UN SDG 3 (Good Health) through work in substance dependence and clinical diagnostics.